These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12482286)

  • 1. Sorsby's fundus dystrophy: what does TIMP3 tell us about general mechanisms underlying macular degeneration?
    Tymms MJ
    Clin Exp Optom; 1999; 82(4):124-129. PubMed ID: 12482286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
    Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH
    Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
    Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
    Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy.
    Gourier HC; Chong NV
    J Clin Med; 2015 May; 4(5):874-83. PubMed ID: 26239453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
    Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH
    J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.
    Felbor U; Doepner D; Schneider U; Zrenner E; Weber BH
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1054-9. PubMed ID: 9152224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
    Li Z; Clarke MP; Barker MD; McKie N
    Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
    Weber BH; Vogt G; Pruett RC; Stöhr H; Felbor U
    Nat Genet; 1994 Dec; 8(4):352-6. PubMed ID: 7894485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization of the human tissue inhibitor of metalloproteinases-3 (TIMP3).
    Stöhr H; Roomp K; Felbor U; Weber BH
    Genome Res; 1995 Dec; 5(5):483-7. PubMed ID: 8808469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
    Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
    Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sorsby's fundus dystrophy. A genetically homogeneous disease].
    Felbor U; Weber BH
    Ophthalmologe; 1998 May; 95(5):287-90. PubMed ID: 9643018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
    Soboleva G; Geis B; Schrewe H; Weber BH
    J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy.
    Fogarasi M; Janssen A; Weber BH; Stöhr H
    Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
    Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
    J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
    Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mutant and wild-type TIMP3 in primary gingival fibroblasts from Sorsby's fundus dystrophy patients.
    Arris CE; Bevitt DJ; Mohamed J; Li Z; Langton KP; Barker MD; Clarke MP; McKie N
    Biochim Biophys Acta; 2003 May; 1638(1):20-8. PubMed ID: 12757930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features.
    Tabata Y; Isashiki Y; Kamimura K; Nakao K; Ohba N
    Hum Genet; 1998 Aug; 103(2):179-82. PubMed ID: 9760202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model for Sorsby fundus dystrophy.
    Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy.
    Wolk A; Hatipoglu D; Cutler A; Ali M; Bell L; Hua Qi J; Singh R; Batoki J; Karle L; Bonilha VL; Wessely O; Stoehr H; Hascall V; Anand-Apte B
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells.
    Grenell A; Singh C; Raju M; Wolk A; Dalvi S; Jang GF; Crabb JS; Hershberger CE; Manian KV; Hernandez K; Crabb JW; Singh R; Du J; Anand-Apte B
    Mol Metab; 2024 Oct; 88():101995. PubMed ID: 39047907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.